[go: up one dir, main page]

ES2009757B3 - Procedimiento para la obtencion de gamma-butirolactamas. - Google Patents

Procedimiento para la obtencion de gamma-butirolactamas.

Info

Publication number
ES2009757B3
ES2009757B3 ES86113938T ES86113938T ES2009757B3 ES 2009757 B3 ES2009757 B3 ES 2009757B3 ES 86113938 T ES86113938 T ES 86113938T ES 86113938 T ES86113938 T ES 86113938T ES 2009757 B3 ES2009757 B3 ES 2009757B3
Authority
ES
Spain
Prior art keywords
butirolactamas
procedure
obtaining gamma
formula
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES86113938T
Other languages
English (en)
Inventor
Wolfgang Hartwig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese Academy of Medical Sciences CAMS and Peking Union Medical College PUMC
Bayer AG
Original Assignee
Chinese Academy of Medical Sciences CAMS and Peking Union Medical College PUMC
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese Academy of Medical Sciences CAMS and Peking Union Medical College PUMC, Bayer AG filed Critical Chinese Academy of Medical Sciences CAMS and Peking Union Medical College PUMC
Application granted granted Critical
Publication of ES2009757B3 publication Critical patent/ES2009757B3/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

EN LA OXIDACION DE COMPUESTOS DE LA FORMULA II SE FORMAN DERIVADOS DE CLAUSENAMIDA DE LA FORMULA I. LOS COMPUESTOS DE LA FORMULA II SE OBTIENEN MEDIANTE UNA SINTESIS EN VARIAS ETAPAS.
ES86113938T 1985-10-18 1986-10-08 Procedimiento para la obtencion de gamma-butirolactamas. Expired ES2009757B3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3537074 1985-10-18
DE19863632589 DE3632589A1 (de) 1985-10-18 1986-09-25 Verfahren zur herstellung von (gamma)-butyrolactamen

Publications (1)

Publication Number Publication Date
ES2009757B3 true ES2009757B3 (es) 1989-10-16

Family

ID=25837071

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86113938T Expired ES2009757B3 (es) 1985-10-18 1986-10-08 Procedimiento para la obtencion de gamma-butirolactamas.

Country Status (11)

Country Link
US (2) US4731455A (es)
EP (1) EP0222163B1 (es)
JP (2) JPH0794431B2 (es)
KR (1) KR870003980A (es)
CN (1) CN1019486B (es)
CA (1) CA1279650C (es)
DE (2) DE3632589A1 (es)
DK (1) DK498286A (es)
ES (1) ES2009757B3 (es)
HU (1) HU198450B (es)
IL (1) IL80305A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616989A1 (de) * 1986-05-21 1987-11-26 Bayer Ag Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung
DE3717395A1 (de) * 1987-05-23 1988-12-08 Basf Ag 5-phenyl-1,2,3a,4,5,9b-hexahydro-3h-benz(e) indole, ihre herstellung und verwendung als arzneimittel
DE3717394A1 (de) * 1987-05-23 1988-12-01 Basf Ag 3-phenyl-2-styryl-pyrrolidine, ihre herstellung und verwendung
EG18833A (en) * 1988-12-09 1994-11-30 Kumiai Chemical Industry Co Cyclic amide compounds and herbicides
DE3927370A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate
EP1326829A2 (en) 2000-09-29 2003-07-16 Bayer Pharmaceuticals Corporation 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
US6787564B2 (en) * 2002-03-26 2004-09-07 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use
JP6059510B2 (ja) * 2012-11-05 2017-01-11 花王株式会社 セラミド産生促進剤
CN118084757B (zh) * 2023-10-10 2025-09-16 广东药科大学 2个内酰胺类物质及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT374457B (de) * 1977-08-18 1984-04-25 Hoechst Ag Verfahren zur herstellung von neuen benzolsulfonamidderivaten
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4454327A (en) * 1982-05-24 1984-06-12 Warner-Lambert Company 5-Oxo-2,2-pyrrolidinedipropanoic acid and ester derivatives thereof
DE3346623A1 (de) * 1983-12-14 1985-07-04 Bayer Ag, 5090 Leverkusen N-glycosylierte harnstoffe, carbamate und thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3508025A1 (de) * 1985-03-07 1986-09-11 Bayer Ag, 5090 Leverkusen Substituierte o-sulfonyl-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS61245606A (ja) * 1985-04-23 1986-10-31 Alps Electric Co Ltd マイクロ波発振器

Also Published As

Publication number Publication date
DK498286A (da) 1987-04-19
DE3632589A1 (de) 1987-04-23
CN86106592A (zh) 1987-06-03
IL80305A (en) 1990-04-29
HUT46661A (en) 1988-11-28
EP0222163B1 (de) 1989-07-19
JPS62187451A (ja) 1987-08-15
IL80305A0 (en) 1987-01-30
KR870003980A (ko) 1987-05-06
DE3664464D1 (en) 1989-08-24
CA1279650C (en) 1991-01-29
JPH0853413A (ja) 1996-02-27
EP0222163A1 (de) 1987-05-20
HU198450B (en) 1989-10-30
JPH0794431B2 (ja) 1995-10-11
US4731455A (en) 1988-03-15
CN1019486B (zh) 1992-12-16
US4803285A (en) 1989-02-07
JP2520582B2 (ja) 1996-07-31
DK498286D0 (da) 1986-10-17

Similar Documents

Publication Publication Date Title
BG30015A3 (bg) Метод за получаване на трифенилалкенови производни
BG41130A3 (en) Method for preparing 8- chlor-1, 5- benzo- thiazepine derivatives
IT1106637B (it) Procedimento per la produzione di policondensati
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
BG41821A3 (en) Method for preparing pyridyl derivatives
BG31649A3 (bg) Метод за получаване на нитросъединения
ES2009757B3 (es) Procedimiento para la obtencion de gamma-butirolactamas.
ES2038176T3 (es) Un procedimiento para la preparacion de derivados del naftaleno.
BG32853A3 (bg) Метод за получаване на 1- оксадетиацефалоспорини
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES462173A1 (es) Procedimiento para la preparacion de derivados de acido 7-a-cilamino-8-oxo-3-oxa-1-azabiciclo-(4,2,0)-octan-2-carboxili-co.
ES2009758B3 (es) Procedimiento para la obtencion de clausenamida.
ES2037770T3 (es) Procedimiento para la preparacion de intermediarios para la sintesis de fosfomicina.
FR2376846A1 (fr) Nouveaux derives de la piperidine
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
ES2038794T3 (es) Procedimiento para la obtencion de derivados del azolil-propenil- y azolilmetiloxirano y fungicidas que les contienen.
ES2052925T3 (es) Compuestos de pirazol, metodo para su produccion, su uso, y compuestos intermedios para la produccion de los mismos.
BG37840A3 (bg) Метод за получаване на производни на ортокондензиран пирол
BG30016A3 (bg) Метод за получаване на бис(нитрозоуреид)-полиолни производни
BG35045A3 (bg) Метод за получаване на заместени триарилтиазолови съединения
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG28415A4 (bg) Метод за получаване на 9-хидроксиоктахидробензо(с) хинолини
BG35031A3 (bg) Метод за получаване на 1,1,2-трифенилпропанови (пропенови) производни
BG35896A3 (en) Method for preparing 3- halogen- 3- cephem compounds
BG30925A3 (en) Method for thiocharbamate derivatives obtaining